73 related articles for article (PubMed ID: 16465049)
41. Polymer controlled drug delivery system for growth hormone.
Gimeno MJ; García-Esteo F; García-Honduvilla N; Bellón JM; Buján J; Román JS
Drug Deliv; 2002; 9(4):233-7. PubMed ID: 12511201
[TBL] [Abstract][Full Text] [Related]
42. Effect of local anti-vascular endothelial growth factor therapy to prevent the formation of stenosis in outflow vein in arteriovenous fistula.
Huang X; Guan J; Sheng Z; Wang M; Xu T; Guo G; Wan P; Tian B; Zhou J; Huang A; Hao J; Yao L
J Transl Int Med; 2021 Dec; 9(4):307-317. PubMed ID: 35136729
[TBL] [Abstract][Full Text] [Related]
43. A biodegradable perivascular wrap for controlled, local and directed drug delivery.
Sanders WG; Hogrebe PC; Grainger DW; Cheung AK; Terry CM
J Control Release; 2012 Jul; 161(1):81-9. PubMed ID: 22561340
[TBL] [Abstract][Full Text] [Related]
44. Correlation of tissue drug concentrations with in vivo magnetic resonance images of polymer drug depot around arteriovenous graft.
Owen SC; Li H; Sanders WG; Cheung AK; Terry CM
J Control Release; 2010 Aug; 146(1):23-30. PubMed ID: 20457189
[TBL] [Abstract][Full Text] [Related]
45. Neointimal hyperplasia associated with synthetic hemodialysis grafts.
Li L; Terry CM; Shiu YT; Cheung AK
Kidney Int; 2008 Nov; 74(10):1247-61. PubMed ID: 18668026
[TBL] [Abstract][Full Text] [Related]
46. Perivascular paclitaxel wraps block arteriovenous graft stenosis in a pig model.
Kelly B; Melhem M; Zhang J; Kasting G; Li J; Krishnamoorthy M; Heffelfinger S; Rudich S; Desai P; Roy-Chaudhury P
Nephrol Dial Transplant; 2006 Sep; 21(9):2425-31. PubMed ID: 16822794
[TBL] [Abstract][Full Text] [Related]
47. In vitro paclitaxel and radiation effects on the cell types responsible for vascular stenosis: a preliminary analysis.
Zhang J; Melhem M; Kassing W; Kelly B; Wang Y; Krishnamoorthy M; Heffelfinger S; Desai P; Roy-Chaudhury P
Blood Purif; 2007; 25(2):155-60. PubMed ID: 17179736
[TBL] [Abstract][Full Text] [Related]
48. A novel technique for loading of paclitaxel-PLGA nanoparticles onto ePTFE vascular grafts.
Lim HJ; Nam HY; Lee BH; Kim DJ; Ko JY; Park JS
Biotechnol Prog; 2007; 23(3):693-7. PubMed ID: 17465527
[TBL] [Abstract][Full Text] [Related]
49. Suppression of neointimal hyperplasia by sirolimus-eluting expanded polytetrafluoroethylene (ePTFE) haemodialysis grafts in comparison with paclitaxel-coated grafts.
Baek I; Bai CZ; Hwang J; Park J; Park JS; Kim DJ
Nephrol Dial Transplant; 2012 May; 27(5):1997-2004. PubMed ID: 22058173
[TBL] [Abstract][Full Text] [Related]
50. Development of a local perivascular paclitaxel delivery system for hemodialysis vascular access dysfunction: polymer preparation and in vitro activity.
Melhem M; Kelly B; Zhang J; Kasting G; Li J; Davis H; Heffelfinger S; Desai P; Roy-Chaudhury P
Blood Purif; 2006; 24(3):289-98. PubMed ID: 16465049
[TBL] [Abstract][Full Text] [Related]
51. Novel therapies for hemodialysis vascular access dysfunction: fact or fiction!
Roy-Chaudhury P; Kelly BS; Melhem M; Zhang J; Li J; Desai P; Munda R; Heffelfinger SC
Blood Purif; 2005; 23(1):29-35. PubMed ID: 15627734
[TBL] [Abstract][Full Text] [Related]
52. Hemodialysis vascular access dysfunction: a cellular and molecular viewpoint.
Roy-Chaudhury P; Sukhatme VP; Cheung AK
J Am Soc Nephrol; 2006 Apr; 17(4):1112-27. PubMed ID: 16565259
[TBL] [Abstract][Full Text] [Related]
53.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
54.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
55.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
